Proposed Data Collection Submitted for Public Comment and Recommendations, 18459-18460 [2017-07902]
Download as PDF
Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices
of seagrass, 650 acres of coastal
wetlands, 14 acres of coastal uplands,
and 1.8 acres of freshwater wetlands.
Habitat restoration includes invasive
removal, sediment contouring, and
native plantings.
Additional information on the TBEP
restoration elements, including metrics
of success, response to science reviews
and more is available in an activityspecific appendix to the FPL, which can
be found at https://
www.restorethegulf.gov. (Please see the
table on page 25 of the FPL and click on:
Tampa Bay Estuary Program,
Implementation.)
Will D. Spoon,
Program Analyst, Gulf Coast Ecosystem
Restoration Council.
BILLING CODE 6560–58–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–0004: Docket No. CDC–2017–
0035]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on the revision of the National
Disease Surveillance Program II Disease
Summaries information collection.
These surveillance data are essential on
the local, state, and federal levels for
measuring trends in diseases, evaluating
the effectiveness of current preventive
strategies, and determining the need to
modify current preventive measures.
DATES: Written comments must be
received on or before June 19, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0035 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
jstallworth on DSK7TPTVN1PROD with NOTICES
VerDate Sep<11>2014
15:06 Apr 18, 2017
Jkt 241001
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2017–07720 Filed 4–18–17; 8:45 am]
SUMMARY:
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
18459
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
National Disease Surveillance
Program II Disease Summaries (OMB
Control Number 0920–0004, Expiration
Date 10/31/2017)—Revision—National
Center for Immunization and
Respiratory Diseases, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC requests a three-year approval for
the revision of the National Disease
Surveillance Program II Disease
Summaries information collection.
As with the previous approval, these
data are essential for measuring trends
in diseases, evaluating the effectiveness
of current preventive strategies, and
determining the need to modify current
preventive measures. The following
diseases in this surveillance program are
Influenza Virus, Caliciviruses,
Respiratory and Enteric Viruses,
Foodborne Outbreaks, Waterborne
Outbreaks and Enteroviruses. Proposed
revisions include form consolidation,
minor revised language and rewording
to improve clarity and readability of the
data collection forms and the
discontinuation of multiple previously
approved influenza collection
instruments, and the National
Respiratory & Enteric Virus Surveillance
System (NREVSS) Laboratory
Assessment (CDC 55.83). CDC requests
the use of a new form, Suspect
Respiratory Virus Patient Form, to assist
health departments and clinical sites
when they submit specimens to the CDC
lab for viral pathogen identification. The
data will enable rapid detection and
characterization of outbreaks of known
pathogens, as well as potential newly
emerging viral pathogens.
The total burden estimate for all
collection instruments in this revision
request is 24,804. The frequency of
response for each form will depend on
the disease and surveillance need. This
represents a 7,117 burden hour
reduction since last approval. This
E:\FR\FM\19APN1.SGM
19APN1
18460
Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices
reduction in burden hours is attributed
primarily to the discontinuation of
previously approved forms and
formatting changes to existing forms.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Epidemiologist ...............
Epidemiologist ...............
NORS Foodborne Disease Transmission_Person to Person Disease Transmission_Animal
Contact_Environmental
Contamination_Unknown Transmission Mode_52.13.
WHO COLLABORATING CENTER FOR INFLUENZA Influenza Virus Surveillance.
U.S. WHO Collaborating Laboratories Influenza
Testing Methods Assessment.
U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) Weekly_CDC 55.20.
U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) Workfolder 55.20E.
Influenza-Associated Pediatric Mortality Case
Report Form.
Human Infection with Novel Influenza A Virus
Case Report Form.
Human Infection with Novel Influenza A Virus
Severe Outcomes.
Novel Influenza A Virus Case Screening Form ..
Antiviral Resistant Influenza Infection Case Report Form.
National Respiratory & Enteric Virus Surveillance System (NREVSS) (55.83A, B, D) (electronic).
National Enterovirus Surveillance Report: (CDC
55.9) (electronic).
National Adenovirus Type Reporting System
(NATRS).
Middle East Respiratory Syndrome (MERS) Patient Under Investigation (PUI) Short Form.
Viral Gastroenteritis Outbreak Submission Form
NORS Waterborne Disease Transmission
Form_52.12..
Influenza Virus (Electronic, Year Round),
PHLIP_HL7 messaging Data Elements.
Influenza virus (electronic, year round) (PHIN–
MS).
Suspect Respiratory Virus Patient Form .............
Total ........................
..............................................................................
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Number of
responses per
respondent
Number of
respondents
Type of respondent
37
20/60
666
53
52
10/60
460
113
1
10/60
19
1,800
52
10/60
15,600
1,800
1
5/60
150
57
2
30/60
57
57
2
30/60
57
57
1
1.5/60
86
57
57
1
3
15/60
30/60
15
86
550
52
15/60
7,150
20
12
15/60
60
13
4
15/60
13
57
3
25/60
72
20
57
5
1
5/60
20/60
9
19
57
52
5/60
247
3
52
5/60
13
10
5
30/60
25
........................
........................
........................
24,804
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–07902 Filed 4–18–17; 8:45 am]
[60Day–17–17ABC; Docket No. CDC–2017–
0033]
Centers for Disease Control and
Prevention
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
jstallworth on DSK7TPTVN1PROD with NOTICES
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
SUMMARY:
VerDate Sep<11>2014
15:06 Apr 18, 2017
Jkt 241001
PO 00000
Frm 00045
Fmt 4703
Total burden
hours
54
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
BILLING CODE 4163–18–P
Average
burden
per response
(in hours)
Sfmt 4703
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled ‘‘Zika
Postpartum Emergency Response
Survey (ZPER), Puerto Rico, 2017.’’
DATES: Written comments must be
received on or before June 19, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0033 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
E:\FR\FM\19APN1.SGM
19APN1
Agencies
[Federal Register Volume 82, Number 74 (Wednesday, April 19, 2017)]
[Notices]
[Pages 18459-18460]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07902]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-17-0004: Docket No. CDC-2017-0035]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on the revision of
the National Disease Surveillance Program II Disease Summaries
information collection. These surveillance data are essential on the
local, state, and federal levels for measuring trends in diseases,
evaluating the effectiveness of current preventive strategies, and
determining the need to modify current preventive measures.
DATES: Written comments must be received on or before June 19, 2017.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0035 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
National Disease Surveillance Program II Disease Summaries (OMB
Control Number 0920-0004, Expiration Date 10/31/2017)--Revision--
National Center for Immunization and Respiratory Diseases, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC requests a three-year approval for the revision of the National
Disease Surveillance Program II Disease Summaries information
collection.
As with the previous approval, these data are essential for
measuring trends in diseases, evaluating the effectiveness of current
preventive strategies, and determining the need to modify current
preventive measures. The following diseases in this surveillance
program are Influenza Virus, Caliciviruses, Respiratory and Enteric
Viruses, Foodborne Outbreaks, Waterborne Outbreaks and Enteroviruses.
Proposed revisions include form consolidation, minor revised language
and rewording to improve clarity and readability of the data collection
forms and the discontinuation of multiple previously approved influenza
collection instruments, and the National Respiratory & Enteric Virus
Surveillance System (NREVSS) Laboratory Assessment (CDC 55.83). CDC
requests the use of a new form, Suspect Respiratory Virus Patient Form,
to assist health departments and clinical sites when they submit
specimens to the CDC lab for viral pathogen identification. The data
will enable rapid detection and characterization of outbreaks of known
pathogens, as well as potential newly emerging viral pathogens.
The total burden estimate for all collection instruments in this
revision request is 24,804. The frequency of response for each form
will depend on the disease and surveillance need. This represents a
7,117 burden hour reduction since last approval. This
[[Page 18460]]
reduction in burden hours is attributed primarily to the
discontinuation of previously approved forms and formatting changes to
existing forms.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Epidemiologist................................. NORS Foodborne Disease 54 37 20/60 666
Transmission_Person to Person Disease
Transmission_Animal
Contact_Environmental
Contamination_Unknown Transmission
Mode_52.13.
Epidemiologist................................. WHO COLLABORATING CENTER FOR INFLUENZA 53 52 10/60 460
Influenza Virus Surveillance.
Epidemiologist................................. U.S. WHO Collaborating Laboratories 113 1 10/60 19
Influenza Testing Methods Assessment.
Epidemiologist................................. U.S. Outpatient Influenza-like Illness 1,800 52 10/60 15,600
Surveillance Network (ILINet)
Weekly_CDC 55.20.
Epidemiologist................................. U.S. Outpatient Influenza-like Illness 1,800 1 5/60 150
Surveillance Network (ILINet)
Workfolder 55.20E.
Epidemiologist................................. Influenza-Associated Pediatric 57 2 30/60 57
Mortality Case Report Form.
Epidemiologist................................. Human Infection with Novel Influenza A 57 2 30/60 57
Virus Case Report Form.
Epidemiologist................................. Human Infection with Novel Influenza A 57 1 1.5/60 86
Virus Severe Outcomes.
Epidemiologist................................. Novel Influenza A Virus Case Screening 57 1 15/60 15
Form.
Epidemiologist................................. Antiviral Resistant Influenza Infection 57 3 30/60 86
Case Report Form.
Epidemiologist................................. National Respiratory & Enteric Virus 550 52 15/60 7,150
Surveillance System (NREVSS) (55.83A,
B, D) (electronic).
Epidemiologist................................. National Enterovirus Surveillance 20 12 15/60 60
Report: (CDC 55.9) (electronic).
Epidemiologist................................. National Adenovirus Type Reporting 13 4 15/60 13
System (NATRS).
Epidemiologist................................. Middle East Respiratory Syndrome (MERS) 57 3 25/60 72
Patient Under Investigation (PUI)
Short Form.
Epidemiologist................................. Viral Gastroenteritis Outbreak 20 5 5/60 9
Submission Form.
Epidemiologist................................. NORS Waterborne Disease Transmission 57 1 20/60 19
Form_52.12..
Epidemiologist................................. Influenza Virus (Electronic, Year 57 52 5/60 247
Round), PHLIP_HL7 messaging Data
Elements.
Epidemiologist................................. Influenza virus (electronic, year 3 52 5/60 13
round) (PHIN-MS).
Epidemiologist................................. Suspect Respiratory Virus Patient Form. 10 5 30/60 25
---------------------------------------------------------------
Total...................................... ....................................... .............. .............. .............. 24,804
--------------------------------------------------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-07902 Filed 4-18-17; 8:45 am]
BILLING CODE 4163-18-P